EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ultra‐Hypofractionated Radiotherapy for Early‐Stage Glottic Cancer: Real‐World Data From a Single Center

Mete Gundog iD, Esin Kiraz iD

Head & Neck · 2025

DOI: 10.1002/hed.28139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Mete Gundog und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Erciyes University, Kayseri, Turkey. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Glottis, Radiation Dose Hypofractionation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In recent years, smaller‐volume radiotherapy has attracted attention. It appears to be a safe and effective treatment for glottic laryngeal cancer. This study evaluated the results of ultra‐hypofractionated radiotherapy for early glottic laryngeal cancer in unfit patients.

Methods

This retrospective study analyzed 22 patients diagnosed with early glottic cancer between June 2017 and January 2021. The involved vocal cord was treated with 35–42.5 Gy in 5 fractions.

Results

On a 59‐month median follow‐up, the 5‐year overall survival and local control rate were 68.2% and 94.7%, respectively. However, the 5‐year larynx preservation rate was 89.7%. Chondronecrosis was observed in one patient (4.5%), and soft tissue necrosis in one patient (4.5%). PTV D98 (> 41.08 Gy) was found to be statistically significant in surgery‐needed events (HR: 22.4, 95% CI: 1.9–252.1, p = 0.01).

Conclusion

Single‐cord ultra‐hypofractionated radiotherapy appears to be an effective treatment for local control. However, the risk of radionecrosis is higher at doses above 41.08 Gy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Laryngeal NeoplasmsGlottisRadiation Dose HypofractionationHumansRetrospective StudiesMaleFemaleMiddle AgedAgedNeoplasm StagingTreatment OutcomeAged, 80 and overAdult

Stichwörter der Autor:innen

laryngeal cancerlocal controlradionecrosisultra‐hypofractionvoice quality

Autor:innen und Institutionen

  • Department of Radiation Oncology, Erciyes University, Kayseri, Turkey.

ORCID-Profile: Mete Gundog, Esin Kiraz

Zitieren

APA

Gundog, M., & Kiraz, E. (2025). Ultra‐Hypofractionated Radiotherapy for Early‐Stage Glottic Cancer: Real‐World Data From a Single Center. Head & Neck. https://doi.org/10.1002/hed.28139

Vancouver

Gundog M, Kiraz E. Ultra‐Hypofractionated Radiotherapy for Early‐Stage Glottic Cancer: Real‐World Data From a Single Center. Head & Neck. 2025. doi:10.1002/hed.28139

BibTeX
@article{Gundog2025,
  author = {Gundog, Mete and Kiraz, Esin},
  title = {Ultra‐Hypofractionated Radiotherapy for Early‐Stage Glottic Cancer: Real‐World Data From a Single Center},
  journal = {Head & Neck},
  year = {2025},
  doi = {10.1002/hed.28139}
}
Kostenlos starten →